These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Duchenne muscular dystrophy and malignant hyperthermia--two case reports. Wang JM; Stanley TH Can Anaesth Soc J; 1986 Jul; 33(4):492-7. PubMed ID: 3742323 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs. Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076 [TBL] [Abstract][Full Text] [Related]
7. [Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics]. Striebel HW; Lechner J; Wiegand C; Hartung E Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):475-80. PubMed ID: 1786310 [TBL] [Abstract][Full Text] [Related]
8. [Two pediatric cases of malignant hyperthermia caused by sevoflurane]. Kinouchi K; Okawa M; Fukumitsu K; Tachibana K; Kitamura S; Taniguchi A Masui; 2001 Nov; 50(11):1232-5. PubMed ID: 11758332 [TBL] [Abstract][Full Text] [Related]
9. Suspected malignant hyperthermia in a child with laminin alpha2 (merosin) deficiency in the absence of a triggering agent. Shukry M; Guruli ZV; Ramadhyani U Paediatr Anaesth; 2006 Apr; 16(4):462-5. PubMed ID: 16618304 [TBL] [Abstract][Full Text] [Related]
10. [A case of malignant hyperthermia; successful treatment with intravenous dantrolene sodium]. Noda B; Higa K; Naitoh H; Dan K Masui; 1985 Jun; 34(6):822-7. PubMed ID: 4032707 [No Abstract] [Full Text] [Related]
11. Malignant hyperthermia in a child with Duchenne muscular dystrophy. Kelfer HM; Singer WD; Reynolds RN Pediatrics; 1983 Jan; 71(1):118-9. PubMed ID: 6848959 [No Abstract] [Full Text] [Related]
12. Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy. Nishiyama K; Kitahara A; Natsume H; Matsushita A; Nakano K; Sasaki S; Genma R; Yamamoto Y; Nakamura H Endocr J; 2001 Apr; 48(2):227-32. PubMed ID: 11456272 [TBL] [Abstract][Full Text] [Related]
13. [A case report of malignant hyperthermia in a 14-month-old boy]. Semmler A; Rieger C; Lesinski R Anaesthesiol Reanim; 1994; 19(1):21-2. PubMed ID: 8141960 [TBL] [Abstract][Full Text] [Related]
14. Improvement of brain electrical activity during treatment of porcine malignant hyperthermia with dantrolene. Kochs E; Hoffman WE; Schulte am Esch J Br J Anaesth; 1993 Dec; 71(6):881-4. PubMed ID: 8280559 [TBL] [Abstract][Full Text] [Related]
16. Dantrolene and the treatment of malignant hyperthermia. Hall GM Br J Anaesth; 1980 Sep; 52(9):847-9. PubMed ID: 7437223 [No Abstract] [Full Text] [Related]
17. Human malignant hyperthermia: awake episodes and correction by dantrolene. Gronert GA; Thompson RL; Onofrio BM Anesth Analg; 1980 May; 59(5):377-8. PubMed ID: 7189384 [No Abstract] [Full Text] [Related]
18. Malignant hyperthermia: clinical course and metabolic changes in two patients. Rutberg H; Håkanson E Acta Anaesthesiol Scand; 1986 Apr; 30(3):211-4. PubMed ID: 3739577 [TBL] [Abstract][Full Text] [Related]
19. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report. Friesen CM; Brodsky JB; Dillingham MF Can Anaesth Soc J; 1979 Jul; 26(4):319-21. PubMed ID: 509349 [TBL] [Abstract][Full Text] [Related]
20. Dantrolene for malignant hyperthermia during anesthesia. Med Lett Drugs Ther; 1980 Jul; 22(15):61-2. PubMed ID: 7393124 [No Abstract] [Full Text] [Related] [Next] [New Search]